News

  1. Aegis Sciences Corporation Provides Insights into Early Detection Methods of COVID-19 Variants

    In collaboration with Walgreens, data analysis examines more than 300,000 COVID-19 samples during Omicron surge NASHVILLE, Tenn., (Oct. 6, 2022) – A manuscript…

    In collaboration with Walgreens, data analysis examines more than 300,000 COVID-19 samples during Omicron surge NASHVILLE, Tenn., (Oct. 6, 2022) – A manuscript detailing an extensive analysis completed by Aegis Sciences Corporation and Walgreens was published in PLOS ONE this week. The manuscript, Validation of reduced S-gene target performance and failure for rapid surveillance of SARS-CoV-2 variants,…

  2. Aegis Sciences Corporation Expands Testing for Novel Psychoactive Substances

     Industry-leading testing offers insight into drug patterns and facilitates informed care Aegis Sciences Corporation, today announced the expansion of…

     Industry-leading testing offers insight into drug patterns and facilitates informed care Aegis Sciences Corporation, today announced the expansion of their proprietary, industry-leading novel psychoactive substance (NPS) testing. The expansion incorporates a wider range of synthetic compounds and refines their current testing capacity, allowing Aegis to track new substances and stay on the forefront…

  3. Aegis Sciences Corporation Now Performs Monkeypox Testing

    Authorized by the CDC as one of five commercial labs to perform these tests nationwide

    Authorized by the CDC as one of five commercial labs to perform these tests nationwide

  4. Aegis Sciences Corporation Designated as a UnitedHealthcare Preferred Lab Network Provider

    Aegis is pleased to announce that it has been chosen to be a part of the UnitedHealthcare Preferred Lab Network (PLN) effective July 1, 2022.The Preferred…

    Aegis is pleased to announce that it has been chosen to be a part of the UnitedHealthcare Preferred Lab Network (PLN) effective July 1, 2022.The Preferred Lab Network consists of currently contracted independent, freestanding laboratory care providers that have met higher standards for access, cost, data, quality and service, based on a rigorous application and review process.For over 30 years, Aegis…

  5. Aegis adopts genotyping approach to track SARS-CoV-2 variants through NIH funded project

    Under contracts with NIH, testing laboratories at Aegis Sciences Corporation, Nashville; Helix, San Diego; and the University of Washington Medical Center,…

    Under contracts with NIH, testing laboratories at Aegis Sciences Corporation, Nashville; Helix, San Diego; and the University of Washington Medical Center, Seattle, have adopted the genotyping approach and are contributing data to the ROSALIND Tracker. This tracking tool—the ROSALIND Tracker for COVID-19 is a free, public dashboard that displays state-by-state the positivity rate and percentage of…

  6. Citing Data Shared by Aegis Sciences, CDC Releases Publication Finding Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

    As the COVID-19 Pandemic continues, there is ongoing significant interest regarding vaccine boosters and the duration of immunity after being vaccinated. …

    As the COVID-19 Pandemic continues, there is ongoing significant interest regarding vaccine boosters and the duration of immunity after being vaccinated.  Last week, the CDC published findings from a recent study assessing COVID-19 infections and test results during periods where Delta or Omicron cases predominated.  This large study, which included over 70,000 test results and information regarding…

  7. Walgreens Launches COVID-19 Index to Advance Rapid Detection of Omicron and Track Variant Activity by State

    Data captured in the Walgreens COVID-19 Index tracks existing and emerging variants DEERFIELD, Ill., and NASHVILLE, Tenn., January 19, 2022 –The Walgreens…

    Data captured in the Walgreens COVID-19 Index tracks existing and emerging variants DEERFIELD, Ill., and NASHVILLE, Tenn., January 19, 2022 –The Walgreens COVID-19 Index, a new interactive tracking tool from Walgreens, powered by testing data from Aegis Sciences Corporation, is among the first to uniquely identify the spread of current and emerging variants in near real-time.New data from the Walgreens…

  8. Aegis Sciences Corporation Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

    HITRUST CSF Certification validates Aegis Sciences Corporation is committed to meeting key regulations and protecting sensitive information. Nashville,…

    HITRUST CSF Certification validates Aegis Sciences Corporation is committed to meeting key regulations and protecting sensitive information. Nashville, TN, January 10, 2022 – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, today announced that several of its applications* have earned Certified…

  9. National Surveillance of COVID-19

    In response to the ongoing COVID-19 pandemic, Aegis Sciences Corporation and Walgreens have collaborated to make real-time reverse transcriptase polymerase…

    In response to the ongoing COVID-19 pandemic, Aegis Sciences Corporation and Walgreens have collaborated to make real-time reverse transcriptase polymerase chain reaction (RT-PCR) testing readily available at more than 5,200 of the over 7,200 Walgreens locations that provide COVID-19 testing.  As the virus that causes COVID-19 continues to mutate, both organizations have worked diligently to closely…

  10. Aegis Sciences Corporation Expands Oral Fluid Testing to include Novel Psychoactive Substances

     Nashville, Tennessee (December 6, 2021) - Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…

     Nashville, Tennessee (December 6, 2021) - Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, is pleased to announce the expansion of oral fluid testing to include novel psychoactive substance (NPS). Testing includes expanded offerings for designer opioids, designer benzodiazepines, synthetic…